35 /100
MEDIUM RISK
Score updated May 30, 2026

TBI — TrueBlue, Inc. Dilution Risk Tracker

Track TBI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TBI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
65
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
24%
📉 Score Deterioration 40%
• Score rose 16 points recently (worsening)
💰 Capital Raise 15%
• Under 12 months cash (9mo)
🔔 Track TBI — Get forecast alerts →

💹 Market Data

Market Cap$188.81M
Shares Outstanding30.40M
Float29.11M
Cash$24.13M
Debt$130.43M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 2.3% shares (2025Q4 vs prior)
108 institutional holders · 27.83M shares
#1 PZENA INVESTMENT MANAGEMENT LLC 2.86M shares
#2 Boston Partners 2.22M shares
#3 BlackRock, Inc. 2.19M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.25M
Days to Cover2.7
% of Float4.3%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Apr 07, 2026
4 INSIDER TRANSACTION Feb 26, 2026
4 INSIDER TRANSACTION Feb 26, 2026
4 INSIDER TRANSACTION Feb 25, 2026
4 INSIDER TRANSACTION Feb 25, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track TBI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TBI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for TBI
📊 TBI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TBI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.